HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment
Yuzhou Shen, Wentao Li Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China Background: Aim of this study was to prepare the hyaluronic acid and human serum albumin modified erlotinib nanoparticles (ERT-HSA-HA NPs) delivery system by a prec...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-07-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/hahsa-co-modified-erlotinib-albumin-nanoparticles-for-lung-cancer-trea-peer-reviewed-article-DDDT |